"Cytochrome P-450 CYP3A/metabolism*"[MeSH Major Topic] - Search Results

Year	Number of Results
2005	14
2006	48
2007	48
2008	108
2009	100
2010	132
2011	143
2012	164
2013	156
2014	169
2015	153
2016	154
2017	139
2018	132
2019	133
2020	122
2021	125
2022	109
2023	111
2024	67

1

Drug metabolism and drug transport of the 100 most prescribed oral drugs.

Iversen DB, Andersen NE, Dalgård Dunvald AC, Pottegård A, Stage TB. Iversen DB, et al. Basic Clin Pharmacol Toxicol. 2022 Nov;131(5):311-324. doi: 10.1111/bcpt.13780. Epub 2022 Aug 24. Basic Clin Pharmacol Toxicol. 2022. PMID: 35972991 Free PMC article. Review.

2

HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview.

Balasubramanian R, Maideen NMP. Balasubramanian R, et al. Curr Drug Metab. 2021;22(5):328-341. doi: 10.2174/1389200222666210114122729. Curr Drug Metab. 2021. PMID: 33459228 Review.

3

Metabolism and interactions of antileprosy drugs.

George J. George J. Biochem Pharmacol. 2020 Jul;177:113993. doi: 10.1016/j.bcp.2020.113993. Epub 2020 Apr 24. Biochem Pharmacol. 2020. PMID: 32339493 Review.

4

Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates.

Otsuka Y, Poondru S, Bonate PL, Rose RH, Jamei M, Ushigome F, Minematsu T. Otsuka Y, et al. J Pharmacokinet Pharmacodyn. 2023 Oct;50(5):365-376. doi: 10.1007/s10928-023-09867-7. Epub 2023 Jun 21. J Pharmacokinet Pharmacodyn. 2023. PMID: 37344637 Free PMC article.

5

Significance of L-carnitine in internal medicine.

Sizova ZM, Shikh EV, Makhova AA. Sizova ZM, et al. Ter Arkh. 2019 Mar 11;91(1):114-128. doi: 10.26442/00403660.2019.01.000040. Ter Arkh. 2019. PMID: 31090382 Review.

6

Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol.

Beers JL, Fu D, Jackson KD. Beers JL, et al. Drug Metab Dispos. 2021 Oct;49(10):882-891. doi: 10.1124/dmd.120.000350. Epub 2021 Jul 30. Drug Metab Dispos. 2021. PMID: 34330718 Free PMC article.

7

Does Crizotinib Auto-Inhibit CYP3A in vivo?

Bland AR, Shrestha N, Rosengren RJ, Ashton JC. Bland AR, et al. Pharmacology. 2020;105(11-12):715-718. doi: 10.1159/000506996. Epub 2020 May 27. Pharmacology. 2020. PMID: 32460299

8

Induction of human hepatic cytochrome P-450 3A4 expression by antifungal succinate dehydrogenase inhibitors.

Kerhoas M, Carteret J, Huchet L, Jouan E, Huc L, Vée ML, Fardel O. Kerhoas M, et al. Ecotoxicol Environ Saf. 2024 May;276:116261. doi: 10.1016/j.ecoenv.2024.116261. Epub 2024 Apr 3. Ecotoxicol Environ Saf. 2024. PMID: 38574644 Free article.

9

Evaluation of the Cytochrome P450 3A and P-glycoprotein Drug-Drug Interaction Potential of Futibatinib.

Yamamiya I, Hunt A, Takenaka T, Sonnichsen D, Mina M, He Y, Benhadji KA, Gao L. Yamamiya I, et al. Clin Pharmacol Drug Dev. 2023 Oct;12(10):966-978. doi: 10.1002/cpdd.1259. Epub 2023 May 3. Clin Pharmacol Drug Dev. 2023. PMID: 37132707

10

Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats.

Suzuki K, Taniyama K, Aoyama T, Watanabe Y. Suzuki K, et al. Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):385-392. doi: 10.1007/s13318-019-00602-7. Eur J Drug Metab Pharmacokinet. 2020. PMID: 32078103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

1,955 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

1,955 results

Results by year